Moreover, neutralizing IL-18 could down-regulate the expression of c-myc and bcl-2 and up-regulate the expression of TP53 and bax, thereby inhibiting cell proliferation, promoting lymphoma cell apoptosis, and enhancing the anti-tumor effect of dexamethasone. Here, BAX is linked to neoplasm.